ATC Group: S02AA15 Ciprofloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S02AA15 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S02 Otologicals
3 S02A Antiinfectives
4 S02AA Antiinfectives
5 S02AA15 Ciprofloxacin

Active ingredients in S02AA15

Active Ingredient Description
Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Related product monographs

Title Information Source Document Type  
CETRAXAL Ear drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CIPROFLOXACIN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CIPROFLOXACIN Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

Israel (IL)

Poland (PL)

Singapore (SG)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.